Valéria Talpe Nunes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Valéria Talpe Nunes has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Adriana Valenzuela
Health Sciences Research Institute (IICS) , National University of Asuncion (UNA) , San Lorenzo , Paraguay
1 shared publication - Alexandra Mercado-Amarilla
Health Sciences Research Institute (IICS) , National University of Asuncion (UNA) , San Lorenzo , Paraguay
1 shared publication - Amalia Castro
Health Sciences Research Institute (IICS) , National University of Asuncion (UNA) , San Lorenzo , Paraguay
1 shared publication - Armando Baena
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health , Rockville, MD
1 shared publication - Elena Kasamatsu
Health Sciences Research Institute (IICS) , National University of Asuncion (UNA) , San Lorenzo , Paraguay
1 shared publication - Hernan Barrios
Health Sciences Research Institute (IICS) , National University of Asuncion (UNA) , San Lorenzo , Paraguay
1 shared publication
Latest Publications
- Open Access
- 1 January 2026
- Published by Wiley in International Journal of Microbiology
- Vol. 2026 (1) , 2292032
Exploring Human Papillomavirus 16 Long Control Region Variants in Paraguayan Women: Comparing Variant Diversity to Transcriptional Activity and Cervical Lesion Severity
Human papillomavirus Type 16 (HPV16) variants are classified into four lineages (A–D) and 16 sublineages: A1–3 (European), A4 (Asian), B1–4 and C1–4 (African), and D1–4 (Asian‐American). This study investigated the genetic HPV16 variability through sequencing of the complete long control region (LCR), in 44 cervical samples from Paraguayan women, including 19 without cervical intraepithelial neoplasia grade 2 (p < 0.05), although none remained statistically significant after correction for multiple comparisons. Notably, most of these mutations were predominantly observed in non‐A1–A3 variants. An exploratory association was observed between non‐A1–A3 variants and the presence of CIN2+ ( p = 0.0065). Functional analysis revealed that the A4 variant, detected in a woman with cancer, exhibited the highest transcriptional activity (2.34 ± 0.78), followed by D3 (0.72 ± 0.21) and A1 (0.03 ± 0.02), corresponding to samples from women with CIN3 and without lesions, respectively. In conclusion, we report for the first time the detection of an A4 HPV16 variant in Paraguay, which exhibited the highest transcriptional activity among the variants analyzed. These findings suggest potential functional differences among HPV16 variants and are consistent with a possible relevance of non‐A1–A3 variants in cervical lesion severity. However, these results should be interpreted with caution as exploratory and hypothesis‐generating.
- 1 January 2026
- Published by Wiley in International Journal of Microbiology
- Vol. 2026 (1) , 2292032
Open AccessExploring Human Papillomavirus 16 Long Control Region Variants in Paraguayan Women: Comparing Variant Diversity to Transcriptional Activity and Cervical Lesion Severity
Human papillomavirus Type 16 (HPV16) variants are classified into four lineages (A–D) and 16 sublineages: A1–3 (European), A4 (Asian), B1–4 and C1–4 (African), and D1–4 (Asian‐American). This study investigated the genetic HPV16 variability through sequencing of the complete long control region (LCR), in 44 cervical samples from Paraguayan women, including 19 without cervical intraepithelial neoplasia grade 2 (p < 0.05), although none remained statistically significant after correction for multiple comparisons. Notably, most of these mutations were predominantly observed in non‐A1–A3 variants. An exploratory association was observed between non‐A1–A3 variants and the presence of CIN2+ ( p = 0.0065). Functional analysis revealed that the A4 variant, detected in a woman with cancer, exhibited the highest transcriptional activity (2.34 ± 0.78), followed by D3 (0.72 ± 0.21) and A1 (0.03 ± 0.02), corresponding to samples from women with CIN3 and without lesions, respectively. In conclusion, we report for the first time the detection of an A4 HPV16 variant in Paraguay, which exhibited the highest transcriptional activity among the variants analyzed. These findings suggest potential functional differences among HPV16 variants and are consistent with a possible relevance of non‐A1–A3 variants in cervical lesion severity. However, these results should be interpreted with caution as exploratory and hypothesis‐generating.